While early diagnosis may not alter long-term outcome, it may provide the patient with an earlier opportunity to evaluate decisions related to pregnancy.
The two most important factors determining management options for pancreatic cancer during pregnancy are disease stage and gestational age.
Prognosis is extremely poor, with 5-year survival after surgery being 20% versus 3-5% in unresectable disease.
Prognosis depends on disease stage and on the interval between diagnosis and surgery.
Delay for even one month may render the disease metastatic.
Participation of a multidisciplinary team is critical in the management of such cases since, due to the rarity of the disease during pregnancy, there are no evidence-based data to guide decisionmaking.
2012-04-24
Eng.
The Journal of reproductive medicine
First Department of Obstetrics and Gynecology, University of Athens, Alexandra Hospital, Athens, Greece. dipapoutsis [at] yahoo.com
J Reprod Med. ;57(3-4):167-70
© Galenicom 1999-2013